Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer

Published:2013-09-06 Issue:1 Volume:48 Page:16-25
ISSN:1869-3474
Container-title:Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Nucl Med Mol Imaging

Author:

Kang Sae-Ryung,Song Ho-Chun,Byun Byung Hyun,Oh Jong-Ryool,Kim Hyeon-Sik,Hong Sun-Pyo,Kwon Seong Young,Chong Ari,Kim Jahae,Cho Sang-Geon,Park Hee Jeong,Kim Young-Chul,Ahn Sung-Ja,Min Jung-Joon,Bom Hee-Seung

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s13139-013-0231-7.pdf

Reference27 articles.

1. World Health Organization. The global burden of disease: 2004 update (2008); Available at http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_part2.pdf . Accessed 7 Feb 2011.

2. American Cancer Society (2010) Cancer Facts and Figures 2010. American Cancer Society. Available at http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf . Accessed 7 Feb 2011.

3. Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010;28:2181–90.

4. O’Rourke N, Roqué I, Figuls M, Farré Bernadó N, Macbeth F. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev. 2010;16:CD002140.

5. Berghmans T, Paesmans M, Sculier JP. Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol. 2011;3:127–38.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison between centralized and asynchronous federated learning approaches for survival outcome prediction using clinical and PET data from non-small cell lung cancer patients;Computer Methods and Programs in Biomedicine;2024-05

2. A computational approach for analysis of intratumoral heterogeneity and standardized uptake value in PET/CT images1;Journal of X-Ray Science and Technology;2023-07-13

3. Deep learning model integrating positron emission tomography and clinical data for prognosis prediction in non-small cell lung cancer patients;BMC Bioinformatics;2023-02-06

4. Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of 18F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer;Cancers;2022-08-17

5. Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment;Cancers;2022-05-23